|
141 |
Pallidal neurostimulation versus botulinum toxin injections in the treatment of cervical dystonia: protocol of a randomized, sham-controlled trial (StimTox-CD)
Enthalten in Neurological research and practice Bd. 1, 28.2.2019, Nr. 1, date:12.2019: 1-8
|
|
|
|
142 |
Plasma autoantibodies to glial fibrillary acidic protein (GFAP) react with brain areas according to Braak staging of Parkinson’s disease
Enthalten in Journal of neural transmission Bd. 129, 1.4.2022, Nr. 5-6, date:6.2022: 545-555
|
|
|
|
143 |
Selecting deep brain stimulation or infusion therapies in advanced Parkinson’s disease: an evidence-based review
Enthalten in Journal of neurology Bd. 260, 5.1.2013, Nr. 11, date:11.2013: 2701-2714
|
|
|
|
144 |
Standardized wireless deep brain stimulation system for mice
Enthalten in npj Parkinson's Disease Bd. 10, 14.8.2024, Nr. 1, date:12.2024: 1-11
|
|
|
|
145 |
Tor1a+/- mice develop dystonia-like movements via a striatal dopaminergic dysregulation triggered by peripheral nerve injury
Enthalten in Acta Neuropathologica Communications Bd. 4, 3.10.2016, Nr. 1, date:12.2016: 1-14
|
|
|
|
146 |
Two years’ experience of implementing a comprehensive telemedical stroke network comprising in mainly rural region: the Transregional Network for Stroke Intervention with Telemedicine (TRANSIT-Stroke)
Enthalten in BMC neurology Bd. 20, 19.3.2020, Nr. 1, date:12.2020: 1-13
|
|
|
|
147 |
Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson’s disease
Enthalten in npj Parkinson's Disease Bd. 4, 10.5.2018, Nr. 1, date:12.2018: 1-7
|
|
Administration
